BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
10/26/2018 11:38:21 AM | Browse: 916 | Download: 1478
 |
Received |
|
2018-07-23 02:46 |
|
Peer-Review Started |
|
2018-07-23 03:58 |
|
To Make the First Decision |
|
2018-08-27 02:31 |
|
Return for Revision |
|
2018-08-28 01:24 |
|
Revised |
|
2018-09-06 10:40 |
|
Second Decision |
|
2018-09-13 08:59 |
 |
Accepted by Journal Editor-in-Chief |
|
|
|
Accepted by Company Editor-in-Chief |
|
2018-10-05 23:15 |
|
Articles in Press |
|
2018-10-05 23:15 |
|
Publication Fee Transferred |
|
|
|
Edit the Manuscript by Language Editor |
|
|
|
Typeset the Manuscript |
|
2018-10-22 07:29 |
|
Publish the Manuscript Online |
|
2018-10-26 11:38 |
| ISSN |
1007-9327 (print) and 2219-2840 (online) |
| Open Access |
This is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/ |
| Copyright |
ⓒ The Author(s) 2018. Published by Baishideng Publishing Group Inc. All rights reserved. |
| Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
| Category |
Gastroenterology & Hepatology |
| Manuscript Type |
Observational Study |
| Article Title |
Long term outcome of antiviral therapy in patients with hepatitis B associated decompensated cirrhosis
|
| Manuscript Source |
Unsolicited Manuscript |
| All Author List |
Young-Cheol Ju, Dae-Won Jun, Jun Choi, Waqar Khalid Saeed, Hyo-Young Lee and Hyun-Woo Oh |
| ORCID |
|
| Funding Agency and Grant Number |
| Funding Agency |
Grant Number |
| The Korean Association for the Study of the Liver |
|
|
| Corresponding Author |
Dae-Won Jun, MD, PhD, Professor, Department of Translational Medicine, Graduate school of Biomedical Science and Engineering, Hanyang University, Department of Internal Medicine, School of Medicine, Hanyang University, 222-1 Wangsimni-ro, Seongdong-gu, Seoul 04763, South Korea. noshin@hanyang.ac.kr |
| Key Words |
Hepatitis B; Antiviral agent; Decompensated cirrhosis; Mortality; Hepatocellular carcinoma |
| Core Tip |
It is well known that antiviral treatment improves clinical outcomes of chronic hepatitis B-associated decompensated cirrhosis. However, long term and large scale clinical data regarding survival rate, and incidence of hepatocellular carcinoma in patients with decompensated cirrhosis in the antiviral era are lacking. We investigated the survival rate and incidence of hepatocellular carcinoma (HCC) in patients with decompensated cirrhosis by using the Health Insurance Review and Assessment database. Long term outcome of treating hepatitis B-associated decompensated cirrhosis using antiviral agents improved much compare to previous reports. Cumulative mortality rate and incidence of HCC was sharply decreased after one year antiviral treatment. |
| Publish Date |
2018-10-26 11:38 |
| Citation |
Ju YC, Jun DW, Choi J, Saeed WK, Lee HY, Oh HW. Long term outcome of antiviral therapy in patients with hepatitis B-associated decompensated cirrhosis. World J Gastroenterol 2018; 24(40): 4606-4614 |
| URL |
http://www.wjgnet.com/1007-9327/full/v24/i40/4606.htm |
| DOI |
http://dx.doi.org/10.3748/wjg.v24.i40.4606 |
© 2004-2024 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
California Corporate Number: 3537345
